AAMC Home   Tomorrow's Doctors Tomorrow's Cures
  Home  Government Affairs   Newsroom   Meetings   Publications Shopping Cart   Site Map    

Washington Highlights:November 5, 2004

GOP Extends Its Control over Congress

Republicans continued their recent domination of national elections on Nov. 2. In addition to President Bush gaining a second term, the GOP increased their advantage in both the Senate and House. In the Senate, Republicans picked up 6 new seats and lost 2, and will hold a 55 to 44 margin, with one Independent, in the 109th Congress. At press time, Republicans had picked up 4 more seats in the House to hold a 231 to 201 margin, with one Independent and 3 seats undecided. The 109th Congress will have three new physicians: Senator-elect Tom Coburn (R-Okla), a family physician, and Rep.-elect Tom Price (R-Ga.), a surgeon, and Rep.-elect Joe Schwarz (R-Mich.), an otolaryngologist, bringing the total number of physicians in Congress to 11.

The Senate will welcome 9 new members: Republicans Richard Burr, (N.C.), Tom Coburn (Okla.), Jim DeMint (S.C.), Johnny Isakson (Ga.), Mel Martinez (Fla.), John Thune (S.D.), David Vitter (La.), and Democrats Barack Obama (Ill.) and Ken Salazar (Colo.). Sen.-elect Thune, who lost his Senate bid in 2002, scored the only victory over an incumbent, defeating Senate Minority Leader Tom Daschle. Six of the new senators have experience in the House: Reps. Burr, DeMint, Isakson, and Vitter are current members, while Sen.-elect Coburn served from 1995 to 2001, and Sen.-elect Thune from 1997 to 2003.

Term limits that Republicans imposed on themselves in 1997, and revised last year, mean that at least 8 Senate committees will get new leaders. Among the changes of interest to academic medicine, Thad Cochran (R-Miss.) is slated to take over Appropriations Committee from Ted Stevens (R-Alaska), who will move to chair the Commerce, Science and Transportation Committee. Larry Craig (R-Idaho) will chair the Veterans' Affairs Committee, which is currently led by Arlen Specter (R-Pa.), who is in line to take over the Judiciary Committee. Retiring Budget Committee Chair Don Nickles (R-Okla) is likely to be replaced by either Judd Gregg (R-N.H.) or Wayne Allard (R-Colo.). If Sen. Gregg takes over Budget, he may be replaced as Chairman of the Health, Education, Labor and Pensions (HELP) Committee by Michael Enzi (R-Wyo.), who is next in line behind Gregg and Senate Majority Leader Bill Frist (R-Tenn.).

The membership of several key committees also will undergo change. Senator Daschle's loss and the retirements of Senators Nickles, John Breaux (D-La.) and Ernest Hollings (D-S.C.) will create several vacancies on the Senate Finance Committee, but the exact number of new seats will not be known until the ratio of Republicans to Democrats on the panel is determined for the 109th Congress. Since the GOP margin in the overall Senate has increased, it is expected Republicans will push for additional seats or to reduce the number of Democrats on committees. The current ratio on the Finance Committee is 11 to 10, with Jim Jeffords (I-Vt.) aligned with the Democrats. Defeated Vice Presidential candidate John Edwards (D-N.C.), whose Senate term expires at the end of the 108th Congress, is the only member of the HELP Committee who is leaving Congress.

In the House, Appropriations Committee Chair C.W. Bill Young (R-Fla.) is term limited, and will be succeeded by one of three current subcommittee chairs: Ralph Regula (R-Ohio), Jerry Lewis (R-Calif.), or Harold Rogers (R-Ky.). James Walsh (R-N.Y) also must give up his chairmanship of the House VA-HUD Appropriations Subcommittee.

Both the House Energy and Commerce Committee and the Ways and Means Committee will lose key members. Energy and Commerce loses Rep. Burr, former committee chairman Billy Tauzin (R-La.), Jim Greenwood (R-Pa.), Peter Deutsch (D-Fla.), Chris John (D-La.), and Karen McCarthy (D-Mo.). Reps. Burr, Greenwood and John were members of the Health Subcommittee. The Ways and Means Committee loses the number two Republican on the committee, Phil Crane (Ill.), as well as Michael Collins (R-Ga.), Jennifer Dunn (R-Wash.), Amo Houghton (R-N.Y.), Scott McInnis (R-Colo.), Jerry Kleczka (D-Wis.), and Max Sandlin (D-Texas). Reps. Crane, Dunn, and Kleczka served on the Ways and Means Health Subcommittee.

Congress returns to Washington Nov. 16 to begin to organize for the 109th Congress and to try to tackle the remaining FY 2005 appropriations bills.

Information:
Dave Moore, Senior Associate Vice President
AAMC Government Relations
dbmoore@aamc.org
(202) 828-0525

AAMC Submits Comments to USDA on the Regulation of Rats, Mice and Birds Not Bred for Research

The AAMC Oct. 28 commented on a U.S. Department of Agriculture (USDA) "advanced notice of proposed rulemaking" on how it should regulate the care and use of rats, mice, and birds not bred for research. Rats, mice and birds bred for research are legislatively exempt from USDA regulation. The letter concluded that the current regulatory regime for rats, mice, and birds not bred for research is adequate and there is no reasonable need for further regulation.

The AAMC endorsed the detailed comments submitted by the National Association for Biomedical Research (NABR), and urged the USDA not to developing specific standards for the nearly 10,000 species of birds, but rather to use the general standards contained in the Animal Welfare Act regulations and then reference existing standards promulgated by societies and associations that have recognized expertise in the care, management and transportation of birds. In the letter, AAMC President Jordan Cohen, M.D., argued "In light of the relatively small number of birds not bred for research used by research institutions and the extraordinarily large number of bird species, we share NABR's view that developing specific regulatory standards for birds is not feasible nor is it prudent, and would provide an inordinate drain on APHIS resources." The AAMC also urged the USDA to use the existing general standards for rats and mice not bred for research. The standards have worked well over the years and AAMC saw no reason for them not to continue to work well.

Information:
Tony Mazzaschi, Senior Associate Vice President
AAMC Biomedical Health Sciences Research
tmazzaschi@aamc.org
(202) 828-0059